NCT02431325View on ClinicalTrials.gov

A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 21, 2020

Study Completion Date

January 21, 2021

Conditions
HIV
Interventions
DRUG

Teduglutide

DRUG

Placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Ragon Institute of MGH, MIT and Harvard

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02431325 - A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV | Biotech Hunter | Biotech Hunter